Congenital Hyperinsulinism
📧 Sign up to get email alerts when something new happens for Congenital Hyperinsulinism.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2016-05-13FDA Approved: PROGLYCEM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for PROGLYCEM (diazoxide) from Teva Pharmaceuticals USA, Inc., likely updating the product label…